Skip to main content
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: ACS Chem Biol. 2013 Aug 13;8(10):2145–2150. doi: 10.1021/cb400430t

Figure 1.

Figure 1

Developing Selective type II kinase inhibitors. A. Docking imatinib into the X-ray co-crystal structure of DDR1; B. Chemical structure of DDR1-IN-1/2 and representative developing rationale; C. DDR1-IN-1 efficacy on blocking DDR1 auto-phosphorylation; D.DDR1-IN-2 efficacy on blocking DDR1 auto-phosphorylation; E. KinomeScan TreeSpot description of the DDR1-IN-1/2 selectivity profile.